EverSource Wealth Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

EverSource Wealth Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$1.07K	–	2635
2023 Q1	$1.07K	Buy	+10	New	+$1.15K	﹤0.01%	2096

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

EverSource Wealth Advisors's RXDX Position: Q2 2023 in Review

EverSource Wealth Advisors sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 10 shares — an estimated $1.07K sold.

EverSource Wealth Advisors first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $1.07K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

EverSource Wealth Advisors reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
EverSource Wealth Advisors sold 10 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $1.07K.
EverSource Wealth Advisors first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
EverSource Wealth Advisors's Prometheus Biosciences, Inc. Common Stock position peaked at $1.07K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on EverSource Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.